接受肾脏替代治疗的危重患者净超滤处方与实践:重症监护从业者多国调查
该多国互联网辅助调查覆盖80个国家14个学会的2567名启动调查的从业者,1569名(61.1%)完成调查,其中72.7%为重症监护医师,执业年限中位13.2年。约71.0%从业者报告使用连续性肾脏替代治疗,血流动力学不稳定患者净超滤率处方中位80.0 mL/hr(四分位距49.0-111.0 mL/hr),血流动力学稳定患者最大速率中位299.0 mL/hr(四分位距200.0-365.0 mL/hr),存在地域差异。仅31.5%从业者在连续性肾脏替代治疗期间每小时评估净液体平衡;报告中20%患者出现血流动力学不稳定时,从业者采取降低液体清除速率(70.3%)、开始或增加血管升压药剂量(51.5%)、完全停止液体清除(35.8%)和给予液体负荷(31.6%),均存在显著地域差异。护士比医师更常报告患者对净超滤不耐受(73.4% vs 81.3%;p=0.002)、频繁中断(40.4% vs 54.5%;p<0.001)和缺乏受训人员(11.9% vs 15.6%;p=0.04),医师更常报告透析机不可用(14.3% vs 6.1%;p<0.001)和治疗费用障碍(12.1% vs 3.0%;p<0.001),均有显著地域差异。作者认为数据反映需要净超滤的循证实践指南。
要点
- 血流动力学不稳定患者连续性肾脏替代治疗净超滤率处方中位80.0 mL/hr(四分位距49.0-111.0 mL/hr),血流动力学稳定患者最大速率中位299.0 mL/hr(四分位距200.0-365.0 mL/hr),存在地域差异。
- 仅31.5%从业者在连续性肾脏替代治疗期间每小时评估净液体平衡(地域范围13.7-47.8%)。
- 报告患者血流动力学不稳定时,70.3%从业者降低液体清除速率,51.5%开始或增加血管升压药剂量,35.8%完全停止液体清除,31.6%给予液体负荷。
- 护士比医师更常报告净超滤不耐受(73.4% vs 81.3%;p=0.002)、频繁中断(40.4% vs 54.5%;p<0.001)和缺乏受训人员(11.9% vs 15.6%;p=0.04)。
- 医师比护士更常报告透析机不可用(14.3% vs 6.1%;p<0.001)和治疗费用障碍(12.1% vs 3.0%;p<0.001)。
适用人群与场景
- 接受肾脏替代治疗的危重急性肾损伤患者。
- 调查对象为参与14个学会、覆盖80个国家的重症监护从业者。
处置流程与药物剂量
- 血流动力学不稳定患者连续性肾脏替代治疗净超滤率处方中位80.0 mL/hr(四分位距49.0-111.0 mL/hr)。
- 血流动力学稳定患者最大净超滤速率中位299.0 mL/hr(四分位距200.0-365.0 mL/hr)。
- 报告患者血流动力学不稳定时,从业者采取降低液体清除速率(70.3%)、开始或增加血管升压药剂量(51.5%)、完全停止液体清除(35.8%)、给予液体负荷(31.6%)。
研究设计与关键结果
- 多国互联网辅助调查,2567名从业者启动调查,1569名(61.1%)完成;72.7%为重症监护医师,执业年限中位13.2年(四分位距7.2-22.0年)。
- 71.0%从业者报告使用连续性肾脏替代治疗(地域范围55.0-95.5%);血流动力学不稳定患者净超滤率处方中位80.0 mL/hr(四分位距49.0-111.0 mL/hr),稳定患者最大速率中位299.0 mL/hr(四分位距200.0-365.0 mL/hr),存在地域差异。
- 仅31.5%从业者每小时评估连续性肾脏替代治疗期间净液体平衡(地域范围13.7-47.8%)。
- 报告中20%患者出现血流动力学不稳定(地域范围20-38%),从业者采取降低液体清除速率(70.3%)、开始或增加血管升压药剂量(51.5%)、完全停止液体清除(35.8%)、给予液体负荷(31.6%),存在显著地域差异。
- 护士 vs 医师:患者对净超滤不耐受73.4% vs 81.3%(p=0.002),频繁中断40.4% vs 54.5%(p<0.001),缺乏受训人员11.9% vs 15.6%(p=0.04);医师 vs 护士:透析机不可用14.3% vs 6.1%(p<0.001),治疗费用障碍12.1% vs 3.0%(p<0.001),均有显著地域差异。
证据类型、等级与局限
- 证据类型:多国互联网辅助调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 调查显示净超滤处方与实践存在国际差异,仅31.5%从业者每小时评估净液体平衡,作者认为数据反映需要净超滤的循证实践指南。
- 护士更常报告净超滤不耐受、频繁中断和缺乏受训人员,医师更常报告透析机不可用和治疗费用障碍,作者将其确定为质量改进的具体靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the attitudes of practitioners with respect to net ultrafiltration prescription and practice among critically ill patients with acute kidney injury treated with renal replacement therapy.
DESIGN: Multinational internet-assisted survey.
SETTING: Critical care practitioners involved with 14 societies in 80 countries.
SUBJECTS: Intervention: MEASUREMENT AND MAIN RESULTS:: Of 2,567 practitioners who initiated the survey, 1,569 (61.1%) completed the survey. Most practitioners were intensivists (72.7%) with a median duration of 13.2 years of practice (interquartile range, 7.2-22.0 yr). Two third of practitioners (71.0%; regional range, 55.0-95.5%) reported using continuous renal replacement therapy with a net ultrafiltration rate prescription of median 80.0 mL/hr (interquartile range, 49.0-111.0 mL/hr) for hemodynamically unstable and a maximal rate of 299.0 mL/hr (interquartile range, 200.0-365.0 mL/hr) for hemodynamically stable patients, with regional variation. Only a third of practitioners (31.5%; range, 13.7-47.8%) assessed hourly net fluid balance during continuous renal replacement therapy. Hemodynamic instability was reported in 20% (range, 20-38%) of patients and practitioners decreased the rate of fluid removal (70.3%); started or increased the dose of a vasopressor (51.5%); completely stopped fluid removal (35.8%); and administered a fluid bolus (31.6%), with significant regional variation. Compared with physicians, nurses were most likely to report patient intolerance to net ultrafiltration (73.4% vs 81.3%; p = 0.002), frequent interruptions (40.4% vs 54.5%; p < 0.001), and unavailability of trained staff (11.9% vs 15.6%; p = 0.04), whereas physicians reported unavailability of dialysis machines (14.3% vs 6.1%; p < 0.001) and costs associated with treatment as barriers (12.1% vs 3.0%; p < 0.001) with significant regional variation.
CONCLUSIONS: Our study provides new knowledge about the presence and extent of international practice variation in net ultrafiltration. We also identified barriers and specific targets for quality improvement initiatives. Our data reflect the need for evidence-based practice guidelines for net ultrafiltration.
参考来源
- Murugan R, Ostermann M, Peng Z, et al. Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners. Crit Care Med. 2020. PMID: 31939807. doi:10.1097/CCM.0000000000004092
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。